A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : OROS

Search Conditions:
Search Keyword : OROS
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: OROS
Appearance Frequency: 108 time(s)
Long forms: 19

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
osmotic-release oral system
(55 times)
Psychiatry
(19 times)
ADHD (37 times)
MPH (17 times)
IR (8 times)
1993 Effect of phenylpropanolamine on energy expenditure and weight loss in overweight women.
osmotic-controlled release oral delivery system
(24 times)
Medicine
(6 times)
ADHD (5 times)
ER (5 times)
MPH (4 times)
2006 Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form.
oral osmotic
(6 times)
Cardiology
(3 times)
CT (1 time)
LA (1 time)
SR (1 time)
1988 Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension.
osmotic controlled-release oral delivery
(3 times)
Mental Disorders
(1 time)
MPH (2 times)
i.v (1 time)
IR (1 time)
2012 Titrating Optimal Dose of Osmotic-Controlled Release Oral Delivery (OROS)-Methylphenidate and Its Efficacy and Safety in Korean Children with ADHD: A Multisite Open Labeled Study.
oral osmotic hydromorphone
(2 times)
Medicine
(1 time)
BPI (1 time)
2014 [Oral osmotic hydromorphone (OROS) in patients with chronic severe pain due to osteoarthritis under daily routine conditions].
ORally OSmotic
(2 times)
Cardiology
(1 time)
AEM (1 time)
1991 A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
osmotic, controlled-release
(2 times)
Medicine
(1 time)
ADHD (1 time)
ADHD-RS (1 time)
MPH (1 time)
2006 Osmotic, controlled-release methylphenidate for the treatment of ADHD.
osmotic, controlled-release formulation
(2 times)
Pharmacology
(2 times)
ADHD (2 times)
d-PPA (1 time)
HCl (1 time)
2000 Dose-proportional and stereospecific pharmacokinetics of methylphenidate delivered using an osmotic, controlled-release oral delivery system.
osmotic-controlled release oral system
(2 times)
Pharmacology
(1 time)
ADHD (2 times)
IDS (1 time)
IR (1 time)
2004 Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study.
10  4-year-old boy who was given 108 mg/day extended-release methylphenidate
(1 time)
Pediatrics
(1 time)
--- 2003 High-dose methylphenidate treatment of attention deficit hyperactivity disorder in a preschooler.
11  once-daily controlled-release formulation of hydromorphone
(1 time)
Drug Therapy
(1 time)
ER (1 time)
MOS (1 time)
OA (1 time)
2007 Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
12  oral dosage form
(1 time)
Drug Therapy
(1 time)
GI (1 time)
Osm (1 time)
2002 Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.
13  oral extended release oxybutynin form
(1 time)
Pharmacology
(1 time)
IVIVC (1 time)
2001 A semiparametric deconvolution model to establish in vivo-in vitro correlation applied to OROS oxybutynin.
14  oral osmotic system
(1 time)
Veterinary Medicine
(1 time)
TTS (1 time)
1985 [Efficient drug forms and the means for using them in the intensive raising of animals].
15  oral release osmotic system
(1 time)
Mental Disorders
(1 time)
ADHD (1 time)
AISRS (1 time)
CGI (1 time)
2006 An open-label trial of OROS methylphenidate in adults with late-onset ADHD.
16  oral, osmotic, controlled-release system
(1 time)
Drug Therapy
(1 time)
ADHD (1 time)
2006 Remission versus response as the goal of therapy in ADHD: a new standard for the field?
17  orosomucoid
(1 time)
Rheumatology
(1 time)
CRP (1 time)
ESR (1 time)
Hb (1 time)
1988 The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis.
18  Osmotic Release Oral System()
(1 time)
Psychiatry
(1 time)
LD (1 time)
2014 Methylphenidate in children with ADHD with or without learning disability.
19  osmotic-release
(1 time)
Substance-Related Disorders
(1 time)
i.v (1 time)
IR (1 time)
MPH (1 time)
2016 Intravenous Use of Prescription Psychostimulants; A Comparison of the Pattern and Subjective Experience between Different Methylphenidate Preparations, Amphetamine and Cocaine.